SPONSOR

University of Alabama at Birmingham

Total Trials

Recruiting

Phases

Phase 2, EARLY_Phase 1

Conditions studied: Mandibular Surgery Rhinosinusitis Dialysis Critically Ill Acute Kidney Injury Renal Replacement Therapy for Acute Kidney Injury in ICU Acute Kidney Injury Renal Replacement Therapy AKI Sickle Cell Disease Adverse Childhood Experiences

University of Alabama at Birmingham is a clinical research sponsor with 23 registered studies on ClinicalTrials.gov, of which 23 are actively recruiting participants. Research covers conditions including Mandibular Surgery, Rhinosinusitis, Dialysis, Critically Ill Acute Kidney Injury.

The trial portfolio spans Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Alabama at Birmingham

How many clinical trials has University of Alabama at Birmingham sponsored?

ClinicalMetric currently tracks 23 clinical trials sponsored by University of Alabama at Birmingham, of which 23 are actively recruiting participants. These trials cover conditions including Mandibular Surgery, Rhinosinusitis, Dialysis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Alabama at Birmingham research focus on?

University of Alabama at Birmingham clinical trials span Mandibular Surgery, Rhinosinusitis, Dialysis, Critically Ill Acute Kidney Injury, Renal Replacement Therapy for Acute Kidney Injury in ICU, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Alabama at Birmingham clinical trial?

To participate in a University of Alabama at Birmingham trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Alabama at Birmingham trials with current recruitment status updated daily.

University of Alabama at Birmingham

Frequently Asked Questions — University of Alabama at Birmingham

Clinical Trials by University of Alabama at Birmingham

Bony Overlap Following Use of the Inferior Border Saw for the 'Low and Short' Sagittal Split: A Split-Mouth Study

Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis

Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America

Early Life Exposures Among Children With Sickle Cell Disease

Adaptation and Evaluation of a Tobacco Cessation Program: An Integrated mHealth Approach

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance

The Effects of Exogenous Ketones on Cognitive Function

Comparison of Healing Measures Tibial Fractures Following Standard Intramedullary Nailing or Micromotion Tibial Intramedullary Nailing

Minority Stress Counseling for LGBTQ+ Individuals

The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury

Improve Cancer-related Cognitive Impairment

Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain Stimulation

Use of Tinted Contact Lenses for Concussion-Related Light Sensitivity

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

Ketogenic Diets for Weight Loss Maintenance: Impact on Energy Expenditure and Appetite in Individuals With Obesity

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia

ME/CFS Brain Fog: Cognitive Rehabilitation Trial

Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants

Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness

Feasibility of a Real-world, Financial Psycho-oncology Intervention to Address Cancer-related Financial Distress

Application to Predict Neonatal Apnea With Bradycardia